Biomedical Sciences ETDs
Publication Date
Summer 7-31-2021
Abstract
Ovarian cancer is the leading cause of gynecologic malignancies, and the patient survival rate has not changed significantly in 20 years. Patients are often diagnosed at an advanced stage of disease with widespread tumor cell dissemination and metastasis. Therefore, drivers of ovarian cancer metastasis need to be identified. In Chapter 2, we reveal the role of Rac1 in ovarian cancer metastasis using a combination of experimental and computational approaches. In Chapter 3, we demonstrate that changes in gene expression and cytokine levels within the immunosuppressive ovarian cancer tumor microenvironment are dependent on Rac1 expression and activity. Collectively, the studies detailed in this dissertation provide evidence that targeting of Rac1 in ovarian cancer has potential therapeutic benefit in decreasing tumor cell dissemination and metastasis.
Keywords
Rho GTPases, Rac1, ovarian cancer, metastasis, agent-based modeling
Document Type
Dissertation
Language
English
Degree Name
Biomedical Sciences
Level of Degree
Doctoral
Department Name
Biomedical Sciences Graduate Program
First Committee Member (Chair)
Dr. Angela Wandinger-Ness
Second Committee Member
Dr. Laurie Hudson
Third Committee Member
Dr. Jennifer Gillette
Fourth Committee Member
Dr. Melanie Moses
Fifth Committee Member
Dr. Mara Steinkamp
Recommended Citation
Rivera, Melanie. "RAC1 IN OVARIAN CANCER METASTASIS AND TUMOR MICROENVIRONMENT REMODELING: AN EXPERIMENTAL AND COMPUTATIONAL ANALYSIS." (2021). https://digitalrepository.unm.edu/biom_etds/304